On August 15th, medical device company Anhan Medical announced that it has invested 100 million U.S. dollars in investment from Dazhong Investment, Softbank China Capital, Advantage Capital, Yusheng Investment, Houxinjiantou and Tongyu Capital for Anhan Medical. Market development and new product line research and development. Previously, in February 2017, Anhan Medical had a strategic cooperation with Softbank China Capital and received 10 million US dollars for medical market development.
According to public information, Anhan Medical was established in 2009. It is a Sino-foreign joint venture high-tech enterprise that develops a capsule endoscope robot system and realizes commercial application. At present, the company's main product is the Navicam capsule endoscope robot system, which is made up of cruise capsules. The endoscope control system is used in combination with the positioning capsule endoscope system. When using the Navicam capsule endoscopic robot for stomach examination, no intubation is required, and only one capsule endoscope is swallowed with water, after about 15 minutes. A painful, non-invasive, non-infectious, no-dead stomach test can be completed.
It is understood that the current Anhan capsule gastroscope robot has the only three types of medical device registration certificates issued by the CFDA that belong to the capsule gastroscope. It has now entered nearly 1,000 medical institutions in 30 provinces and cities nationwide, and its market is stable at 40 million per year. The demand for the population includes gastric patients, high-risk groups of gastric cancer, physical examination population, and cardiology patients.
Industrial Gelatin,Industrial Hide Gelatin Powder,Industrial Gelatin For Woodworking,Industrial Gelatin For Abrasive Paper
Hebei Haodong Biological Technology Co.,Ltd. , https://www.hdgelatin.com